Medicinal-Chemistry Mcqs 1

Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

Medicinal Chemistry 1 MCQs [set-1]

Chapter: Introduction, History and development of Medicinal Chemistry

1. Aspirin is introduced by_________in 1889


A. Dreser's
B. Emil Fischer and Mering
C. Barger and Dale
D. None of above
Answer: A

2. First hormone epinephrine was synthesized in Year


A. 1903
o m
B. 1904
. c
C. 1909
te
D. 1889
a
Answer: B

q M
c
3. Who is founder of modem medicine?
A. Hippocartes M
B. Clark
C. Charak
D. Henry's
Answer: A

4. Identification of a new chemical entity as a potential therapeutic agent (From


Hit to Lead) is known as
A. Drug discovery
B. Drug development
C. Both of above
D. None of above
Answer: A

5. The process of bringing a new pharmaceutical drug to the market once the lead
compound has been identified through the process of drug discovery. (From Lead
to NDA) is known as
A. Drug discovery
B. Drug development
C. Both of above
D. None of above
Answer: B

6. Natural products or derivatives or synthetic substances with good binding ability


in Drug discovery is known as
A. Hit
B. Lead
C. NDA
D. IND
Answer: A

7. Compound with good activity and selectivity in screening during drug discovery
is known as
A. Hit
B. Lead
C. NDA
D. IND
Answer: B

8. The main goals of pre-clinical studies


A. To determine the safe dose for first-in-man study
B. To assess a product's safety profile
C. A and B both
D. None
Answer: C

9. IND stands for


A. Improved new drug
B. Investigational new drug
C. International new drug
D. International novel drug
Answer: B

View all MCQ's at McqMate.com


10. Human micro dosing studies conducted in which clinical phase ?
A. Phase 0
B. Phase I
C. Phase II
D. Phase III
Answer: A

11. MTD is
A. Maximum targeted dose
B. Minimum tolerated dose
C. Minimum targeted dose
D. Maximum tolerated dose
Answer: D

12. Single ascending dose studies are done in_____


A. Phase lb
B. Phase Ia
C. Phase II
D. Phase Ila
Answer: B

13. NDA is
A. New Drug Application
B. New Drug approval
C. Noval Drug Admistration
D. New Drug agenda
Answer: A

14. Phase IV trial is also known


A. Base of clinical trial
B. Multiple ascending dose era
C. Post marketing Surveillance
D. Pre-clinical trial
Answer: C

15. How many people will be selected for phase I trial?


A. The whole market will be under surveillance

View all MCQ's at McqMate.com


B. 300-3000 people
C. 20-300 people
D. 20-50 people
Answer: D

16. How many people will be selected for phase II trial?


A. The whole market will be under surveillance
B. 300-3000 people
C. 20-300 people
D. 20-50 people
Answer: C

17. How many people will be selected for phase III trial?
A. The whole market will be under surveillance
B. 300-3000 people
C. 20-300 people
D. 20-50 people
Answer: B

18. Which one of the following will be checked under phase IV surveillance?
A. The whole market will be under surveillance
B. 300-3000 people
C. 20-300 people
D. 20-50 people
Answer: A

19. Precision Medicine is an emerging approach depending on


A. Genomic study of individual
B. Diagnostic process of individual
C. Diseases conditions
D. None of above
Answer: A

20. How many main families of GPCRs are there?


A. 5
B. 6
C. 7

View all MCQ's at McqMate.com


D. 4
Answer: B

21. Which of the following reactions is catalyzed by the enzyme adenylate cyclase?
A. Conversion of ATP to cyclic AMP
B. Conversion of cyclic AMP to AMP
C. Conversion of cyclic AMP to ATP
D. Conversion of AMP to cyclic AMP
Answer: A

22. Oxadiazole ring contains


A. 1 Nitrogen /Oxygen
B. 2 Oxygen/ Nitrogen
C. 2 Nitrogen/Sulphur
D. 2 Nitrogen/Oxygen
Answer: D

23. The hetroaromatic redical is called


A. Anthryl
B. Naphthyl
C. Phenanthryl
D. Dibenzyl
Answer: B

24. Name of this aromatic ring is


A. Diphenylmethyl ethane
B. 2-ethyl-1-methyl naphthalene
C. 1-ethyl-2-methyl naphthalene
D. 1-ethyl-1-methyl naphthalene
Answer: C

25. Name of this aromatic ring is


A. Azopane
B. Azepine
C. Azepane
D. None of above
Answer: C

View all MCQ's at McqMate.com

You might also like